[1]
2026. Prognostic value of Ki67 and PSA-immunostaining in de novo metastatic hormone-sensitive prostate cancer. Archivio Italiano di Urologia e Andrologia. 98, 1 (Mar. 2026). DOI:https://doi.org/10.4081/aiua.2026.14731.